A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Sarcoidosis-associated Pulmonary Hypertension
In brief
Oral selexipag is commercially available in several countries for the treatment of a particular group of pulmonary hypertension (PH) called pulmonary arterial hypertension (PAH). The aim of the present study is to investigate whether selexipag could be helpful to treat patients with another form of PH called sarcoidosis-associated pulmonary hypertension (SAPH).
Key facts
- Study ID
- NCT03942211
- Run by
- Actelion
- People needed
- 10
- Starts
- 2021-02-26
- Expected to finish
- 2023-04-19
- Last updated by the study team
- 2024-05-08
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Vincent Medical Group, Inc. — Indianapolis, Indiana, United States
- LSU Health Sciences Center New Orleans — New Orleans, Louisiana, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
- Duke University Medical Center — Durham, North Carolina, United States
- University of Cincinnati — Cincinnati, Ohio, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- Medical University of South Carolina (MUSC) - College of Medicine (COM) — Charleston, South Carolina, United States
- Universitaire Ziekenhuizen Leuven — Leuven, Belgium
- Secretaria da Saude do Estado do Ceara - Hospital Doutor Carlos Alberto Studart Gomes — Fortaleza, Brazil
- Hospital das Clinicas de Porto Alegre — Porto Alegre, Brazil
- Hospital Das Clinicas Da Faculdade De Medicina Da USP — São Paulo, Brazil
- London Health Sciences Centre — London, Ontario, Canada
- Jewish General Hospital — Montreal, Quebec, Canada
- Hôpital Avicenne — Bobigny, France
- GH est - Hôpital Cardiovasculaire et Pneumologie Louis Pradel — Bron, France
- Hôpital Kremlin Bicêtre — Le Kremlin-Bicêtre, France
- Hopital Nord — Marseille, France
- CHU de Nancy - Hopital de Brabois — Vandœuvre-lès-Nancy, France
- Evangelische Lungenklinik Berlin — Berlin, Germany
- Universitatsklinikum Bonn — Bonn, Germany
- Universitatsklinikum Carl Gustav Carcus Dresden — Dresden, Germany
- Thoraxklinik Heidelberg — Heidelberg, Germany
- Universitatsklinikum Schleswig Holstein — Lübeck, Germany
- Universitaetsklinikum Regensburg — Regensburg, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.